The Indian government will not allow the export of the Oxford University-AstraZeneca vaccine manufactured by the Serum Institute of India for several months. The coronavirus vaccine was granted approval for emergency use authorisation by the Indian drug regulator on Sunday. Serum Institute CEO Adar Poonawalla said in an interview that the emergency use approval was granted on the condition that the company does not export the shots to ensure that the vulnerable in India are protected.
The Indian government will not allow the export of the Oxford University-AstraZeneca vaccine manufactured by the Serum Institute of India for several months. The coronavirus vaccine was granted approval for emergency use authorisation by the Indian drug regulator on Sunday. Serum Institute CEO Adar Poonawalla said in an interview that the emergency use approval was granted on the condition that the company does not export the shots to ensure that the vulnerable in India are protected.